Taihaomed
Taipei, Taiwan· Est.
AI‑enabled imaging platform that accelerates and standardizes breast and lung diagnostics.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
AI‑enabled imaging platform that accelerates and standardizes breast and lung diagnostics.
Oncology
Technology Platform
Deep‑learning‑based image analysis that provides real‑time lesion detection, CAD assistance, and automated reporting for ultrasound and low‑dose CT scans.
Opportunities
Expansion into additional imaging indications and deeper integration with EMR/tele‑medicine platforms can broaden market reach across Asia and North America.
Risk Factors
Regulatory hurdles in new jurisdictions and intense competition from established OEMs and AI startups could limit adoption and pricing power.
Competitive Landscape
TaiHao competes with large imaging manufacturers (Siemens, Philips, GE) and AI‑focused startups (Aidoc, Zebra Medical Vision); its differentiation lies in early regulatory clearances and specialized breast/ultrasound AI solutions.